BridgeBio Pharma
BBIO
BBIO
210 hedge funds and large institutions have $6.56B invested in BridgeBio Pharma in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 83 increasing their positions, 61 reducing their positions, and 18 closing their positions.
Holders
210
Holders Change
+10
Holders Change %
+5%
% of All Funds
3.69%
Holding in Top 10
15
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.26%
New
30
Increased
83
Reduced
61
Closed
18
Calls
$19.6M
Puts
$25M
Net Calls
-$5.4M
Net Calls Change
+$4.12M
Top Buyers
| 1 |
1
BlackRock
New York
|
$475M |
| 2 |
2
Fisher Asset Management
Camas,
Washington
|
$26.7M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$145M |
| 4 |
4
Charles Schwab
San Francisco,
California
|
$49.1M |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$79.1M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
IA
226
IFP Advisors
Tampa,
Florida
| – | – | – | – |
|
227
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
228
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CM
229
Caption Management
Oklahoma City,
Oklahoma
| – | – | – | – |
|
230
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
231
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
WAM
232
Wolverine Asset Management
Chicago,
Illinois
| – | – | – | – |
|
|
SM
233
SG3 Management
Dorado,
Puerto Rico
| – | – | – | – |
|
|
AC
234
Athanor Capital
New York
| – | – | – | – |
|
|
CAC
235
Cowen and Company
New York
| – | – | – | – |
|
|
CG
236
Cutler Group
San Francisco,
California
| – | – | – | – |
|
|
HI
237
Harbour Investments
Madison,
Wisconsin
| $0 | 2 | +1 | +100% |
|
238
CI Investments Inc
Toronto,
Ontario, Canada
| $0 | 6 | +6 | New |
|
|
EVM
239
Eaton Vance Management
Boston,
Massachusetts
| $0 | 487 | +487 | New |
|